preliminary-issue-analysis-memo.docx

1023-00003 · Ironside Capital Management LP · Analysis

preliminary-issue-analysis-memo.docx DOCUMENT M&A / Corporate

3 / 12 ← → ✕

CALDERWOOD & HARKNESS LLP 1251 Avenue of the Americas, 40th Floor New York, New York 10020 Telephone: (212) 558-4000 Facsimile: (212) 558-3588

INTERNAL MEMORANDUM

April 21, 2023

TO: Sylvia Hartwell, Partner, Tax Department

FROM: Leila Nazari, Associate, Tax Department Robert Jansen, Associate, Tax Department

RE: Preliminary Issue Analysis and Defense Strategy — IRS Examination of Ironside Capital Management LP (EIN 83-2741956), Form 1065, Tax Year Ended December 31, 2021

MATTER NO.: 1023-00003

I. Executive Summary

Calderwood & Harkness LLP was engaged on April 10, 2023 to represent Ironside Capital Management LP ("ICM" or the "Fund"), a Delaware limited partnership (EIN 83-2741956) headquartered at 590 Madison Avenue, 28th Floor, New York, New York 10022, in connection with an IRS Large Business & International Division ("LB&I") examination of ICM's 2021 partnership tax return (Form 1065), which was filed on extension on September 15, 2022 by Borwick Craine & Associates LLP, ICM's outside auditor and tax return preparer.

The examination was initiated by IRS Letter 2205-D dated March 22, 2023, which was received by ICM on March 29, 2023. The examination has been assigned to the Pass-Through Entities Practice Area of the LB&I Division at the IRS Manhattan Campus, located at 290 Broadway, New York, New York 10007. The lead examiner is Revenue Agent Timothy J. Albrecht (GS-13, Badge No. 74-28193), with supporting agent Dawn M. Petrovic (GS-12). The territory manager overseeing the examination is Karen P. Driscoll.

Upon engagement, the firm promptly filed Form 2848 (Power of Attorney and Declaration of Representative) on April 14, 2023, designating Sylvia Hartwell and Leila Nazari as authorized representatives of ICM before the Internal Revenue Service. This designation ensures that all IRS communications related to the examination will be directed to the firm rather than to the client directly, allowing us to maintain control over the flow of information and the development of the defense strategy.

The firm was initially contacted on April 5, 2023 by Marcus Trent, General Counsel of ICM, who serves as the primary client liaison for this matter. Mr. Trent has been cooperative and responsive to date and has expressed a willingness to make ICM's personnel, records, and third-party service providers available as needed for the defense.

Based on our initial review of the 2021 Form 1065, the underlying workpapers prepared by Borwick Craine & Associates LLP, and the ICM Limited Partnership Agreement dated June 14, 2016 (as amended through the Fourth Amendment dated March 1, 2020) (collectively, the "LPA"), we have identified three primary issues that the IRS is likely to examine during the course of this audit. These issues align with known LB&I campaign priorities targeting hedge fund and private equity fee structures, as well as with scope indicators discernible from the examination notification letter. This memorandum provides a preliminary analysis of each issue, quantifies the potential exposure at both the partnership and partner levels, and recommends a comprehensive defense strategy.

The total potential partnership-level adjustment across all three issues is approximately $63.18 million. The estimated aggregate tax impact across all partners, taking into account applicable rate differentials, is approximately $11.78 million. While this aggregate exposure is substantial, we believe that all three positions taken on ICM's 2021 Form 1065 are defensible, provided that adequate documentation can be assembled and well-supported legal arguments are presented to the examining agents. The strength of the defense varies by issue, as detailed below, but none of the three issues presents an exposure that, in our preliminary judgment, would warrant concession at this stage.

This memorandum is intended to serve as a working document to guide the defense strategy. It will be updated as the examination progresses, as we receive and review additional documents from the client and third-party service providers, and as the IRS clarifies its areas of focus through the issuance of Information Document Requests and other examination activity.

II. Client and Fund Overview

A. Entity Structure

Ironside Capital Management LP is a Delaware limited partnership formed on June 14, 2016 pursuant to a Certificate of Limited Partnership filed with the Delaware Secretary of State. ICM's registered agent in Delaware is Capitol Statutory Services LLC, located at 1209 Orange Street, Wilmington, Delaware 19801. ICM maintains its principal office at 590 Madison Avenue, 28th Floor, New York, New York 10022, and is registered to do business in the State of New York.

The general partner of ICM is Ironside Capital GP LLC, a Delaware limited liability company (EIN 83-2741890), which was also formed on June 14, 2016. Ironside Capital GP LLC is the sole general partner of ICM and is responsible for the management, control, and operation of the Fund's business, including all investment decisions, in accordance with the terms of the LPA.

The managing members of Ironside Capital GP LLC are as follows:

• Desmond R. Calloway — Founder and Chief Investment Officer. Mr. Calloway holds a 62% membership interest in Ironside Capital GP LLC. As of December 31, 2021, his capital account in ICM (inclusive of amounts attributable to his interest in the GP and any direct investment) was approximately $187.4 million. Mr. Calloway is ultimately responsible for all portfolio management and investment strategy decisions.

• Priya Venkatesh — Chief Operating Officer and Chief Financial Officer. Ms. Venkatesh holds a 28% membership interest in Ironside Capital GP LLC. As of December 31, 2021, her capital account in ICM was approximately $48.6 million. Ms. Venkatesh oversees the Fund's operations, financial reporting, compliance, and relationships with service providers, including the fund administrator, prime broker, and outside auditors.

• Other GP Members — The remaining 10% membership interest in Ironside Capital GP LLC is held by other members of the GP entity, whose identities and interests are not material to the issues under examination and are not discussed in detail in this memorandum.

The partnership structure of ICM is a standard two-tier hedge fund structure, with investors (limited partners) making capital commitments to the Fund, and the GP managing the Fund in exchange for management fees and performance-based allocations (carried interest). There are no blocker entities or feeder funds that are relevant to the current examination, although we note that certain limited partners invest through their own tiered structures, which increases the total number of Schedule K-1s issued by the Fund beyond the number of direct partners.

B. Fund Operations and Financials (Tax Year 2021)

ICM operates as a multi-strategy hedge fund, deploying capital across three principal investment strategies: (i) global macro, encompassing positions in sovereign debt, currencies, commodities, and macroeconomic derivatives; (ii) event-driven equity, focused on corporate events such as mergers, acquisitions, restructurings, and spin-offs; and (iii) credit strategies, including distressed debt, structured credit, and high-yield fixed income. The multi-strategy approach is designed to generate risk-adjusted returns across a range of market environments while providing diversification benefits to the portfolio.

As of December 31, 2021, ICM's total assets under management ("AUM") were approximately $3.82 billion, as reported on ICM's 2021 Form 1065, Schedule L (Balance Sheets per Books). This figure reflects the aggregate net asset value of the Fund's portfolio, inclusive of all investment positions, cash, and other assets, net of liabilities.

The Fund had a total of 47 limited partners as of December 31, 2021, plus the general partner. The limited partner base consists of a mix of institutional investors, family offices, endowments, and high-net-worth individuals. Key limited partners referenced in the course of our initial review include:

• Northgate Public Employees' Retirement System — a public pension fund with a capital commitment to ICM of approximately $412 million, making it the Fund's largest single investor by committed capital.

• Bramblewood Family Office LLC — a private family office with a capital commitment of approximately $95 million.

• Marlowe Asset Management Horizon Endowment Fund — a university endowment fund with a capital commitment of approximately $175 million.

These investors are identified here for context only; their individual tax situations are not directly at issue in the partnership-level examination, although any partnership-level adjustments will flow through to their respective Schedules K-1 pursuant to the Bipartisan Budget Act partnership audit rules.

The Fund's compensation structure for the GP is as follows:

Management Fee. Pursuant to LPA § 4.1, the GP is entitled to an annual management fee equal to 2% of committed capital. For the tax year ended December 31, 2021, average committed capital was approximately $3.58 billion, resulting in total management fees of approximately $71.6 million ($3.58 billion × 2%). The management fee is paid quarterly in advance, calculated as one-quarter of the annual rate applied to committed capital as of the first business day of each quarter, subject to certain adjustments specified in the LPA.

Carried Interest (Performance Allocation). Pursuant to LPA § 5.2, the GP is entitled to a performance allocation equal to 20% of the net profits of the Fund in excess of an 8% preferred return hurdle (the "Hurdle Rate"), with a full catch-up provision allowing the GP to receive 100% of profits above the Hurdle Rate until the GP has received its full 20% allocation of cumulative profits. For the tax year ended December 31, 2021, total performance allocations to the GP were approximately $94.3 million, as reported on the Schedule K-1 issued to Ironside Capital GP LLC. Based on the Fund's AUM and these performance figures, the implied gross fund return for 2021 was approximately 18.7%, substantially exceeding the 8% Hurdle Rate and triggering the full catch-up and carried interest allocation.

The Fund's principal third-party service providers relevant to this engagement are:

• Fund Administrator: Greystone Fund Administration LLC. Greystone is responsible for the Fund's net asset value calculations, capital account maintenance, management fee and performance allocation computations, investor reporting, and financial statement preparation.

• Prime Broker: Ridgeline Securities LLC. Ridgeline provides trade execution, clearing, settlement, custody, and securities lending services to the Fund. Ridgeline maintains the official trade records, account statements, and trade confirmations that will be central to the defense of Issue 2 (carried interest holding period).

• Auditor and Tax Return Preparer: Borwick Craine & Associates LLP. Fenwick Craine serves as the Fund's independent auditor and also prepares the Fund's annual partnership tax return (Form 1065) and all related Schedules K-1. The audit engagement partner is Sandra Whitmore, CPA, and the tax engagement partner is Elliot Navarro, CPA. Fenwick Craine's office is located at 3 World Financial Center, Suite 2400, New York, New York 10281. As the return preparer and auditor, Fenwick Craine will be a critical source of workpapers and supporting documentation for all three issues under examination.

III. Examination Scope and Status

As of the date of this memorandum, the IRS has not yet issued its first Information Document Request ("IDR"). Based on our experience with LB&I examinations of this nature and the timeline typically followed by examiners at the Manhattan Campus, we anticipate receiving IDR #1 within the next one to two weeks. We expect that IDR #1 will be a general books-and-records request, seeking the Fund's complete partnership return, supporting schedules, financial statements, LPA, organizational documents, and related materials. Subsequent IDRs will likely become more targeted as the examination progresses and Revenue Agent Albrecht identifies specific areas of inquiry.

Based on the Letter 2205-D and our initial correspondence with the IRS, the examination is focused on partnership-level items. Under the centralized partnership audit rules enacted by the Bipartisan Budget Act of 2015 ("BBA"), codified at IRC §§ 6221 through 6241, ICM is subject to the partnership-level examination and adjustment regime for its 2021 tax year. No election out of the BBA rules was made under IRC § 6221(b), as the Fund is ineligible for such an election: when tiered partner structures are taken into account, the Fund effectively issues more than 100 Schedules K-1, exceeding the statutory threshold. Marcus Trent, ICM's General Counsel, has been designated as the "partnership representative" within the meaning of IRC § 6223, and he has designated Sylvia Hartwell as the partnership representative's authorized designee.

The BBA framework has significant procedural and substantive implications for the defense strategy. Under the BBA, any imputed underpayment resulting from a partnership-level adjustment is assessed and collected at the partnership level, unless the partnership elects under IRC § 6226 to push out the adjustments to its partners. We will need to evaluate the relative advantages and disadvantages of a push-out election as the examination progresses, taking into account the composition of the partner base, the tax-exempt or reduced-rate status of certain partners (such as Northgate Public Employees' Retirement System), and the availability of modification procedures under IRC § 6225(c) that could reduce any imputed underpayment.

Based on the scope indicators in the notification letter, the IRS's known audit campaigns targeting hedge fund and private equity fee arrangements, and our substantive review of the return, we anticipate three principal examination issues:

1. Management Fee Waiver / Conversion — Whether Ironside Capital GP LLC's waiver of $23.8 million in management fees in exchange for an increased capital interest constitutes a disguised payment for services under IRC § 707(a)(2)(A).

2. Carried Interest Holding Period — Whether $38.7 million of performance allocations to the GP, attributable to 14 liquidated positions, satisfies the three-year holding period requirement under IRC § 1061 for long-term capital gain treatment on applicable partnership interests.

3. Organizational and Syndication Cost Deductions — Whether $680,000 of expenses deducted (as amortized organizational expenses under IRC § 709(b)) should instead be classified as non-deductible, non-amortizable syndication costs under IRC § 709(a).

Each of these issues is analyzed in detail in Sections IV through VI below.

IV. Issue 1: Management Fee Waiver / Conversion — IRC § 707(a)(2)(A)

A. Factual Background

In the tax year ended December 31, 2021, Ironside Capital GP LLC exercised its right under LPA § 4.1(c) to waive a portion of its management fee entitlement in exchange for an increased capital interest in the Fund. Specifically, the GP waived $23.8 million of its total $71.6 million management fee entitlement for 2021. The remaining $47.8 million in management fees was received by the GP in the ordinary course and reported as ordinary income on the Fund's Form 1065 and the GP's Schedule K-1.

The economic effect of the waiver was to convert what would otherwise have been ordinary income — management fees taxable at the top marginal ordinary income rate of 37%, plus the 3.8% Net Investment Income Tax ("NIIT") under IRC § 1411, for a combined rate of 40.8% — into a capital interest in the Fund. That capital interest, upon subsequent appreciation and disposition, would generate long-term capital gain taxable at a combined rate of 23.8% (20% plus 3.8% NIIT), representing a rate differential of approximately 17 percentage points.

The waiver was effected pursuant to a specific mechanism set forth in LPA § 4.1(c), which provides that the GP may elect, prior to the beginning of each fiscal year, to waive all or a portion of its management fee for the upcoming fiscal year in exchange for an equivalent increase in its capital account. Under the terms of the LPA, such waiver is treated as a capital contribution by the GP to the Fund in an amount equal to the waived fee. The LPA expressly states that the increased capital interest resulting from the waiver is treated identically to all other limited partner capital for purposes of investment allocation, liquidity restrictions, and the partnership's distribution waterfall.

Our initial review of the contemporaneous documentation indicates that the waiver election for the 2021 fiscal year was made prior to the beginning of the fiscal year, consistent with the prospective election requirement of LPA § 4.1(c). The documentation supporting the waiver includes:

(i) A resolution of the managing members of Ironside Capital GP LLC, dated November 18, 2020, approving the GP's election to waive $23.8 million of its 2021 management fee entitlement;

(ii) An internal memorandum prepared by Priya Venkatesh, dated November 15, 2020, analyzing the economic and tax implications of the waiver election and recommending the waiver amount; and

(iii) A notification letter from the GP to the Fund Administrator (Greystone Fund Administration LLC), dated December 1, 2020, instructing Greystone to implement the waiver by crediting the GP's capital account with the waived amount ratably over the four quarterly management fee payment dates in 2021.

We have not yet reviewed the complete set of supporting documentation, and one of the action items identified in Section VIII of this memorandum is to obtain and thoroughly review all records related to the waiver election.

The economic substance of the waiver is a critical factual consideration. Under the terms of the LPA, the GP's waived management fees were converted into an unrestricted capital interest in the Fund, subject to the same investment risk, liquidity terms, and allocation methodology as all other partner capital. The waived amount was invested in the Fund's multi-strategy portfolio — the same pool of global macro, event-driven equity, and credit investments in which all limited partner capital is deployed. The GP's increased capital interest was not placed in a segregated side pocket, was not subject to a guaranteed or preferred return, and was not otherwise afforded any form of principal protection or downside mitigation. In short, the GP bore the full risk of loss on the waived amount, just as any other partner would on its committed capital.

This factual point is central to the defense, as discussed in Sections B through D below.

B. Applicable Legal Authority

The primary statutory authority governing this issue is IRC § 707(a)(2)(A), which provides that, if a partner performs services for a partnership, and there is a related direct or indirect allocation and distribution to such partner, and the performance of such services and the allocation and distribution, when viewed together, are properly characterized as a transaction occurring between the partnership and a partner acting other than in his capacity as a member of the partnership, then such transaction shall be treated as a transaction between the partnership and one who is not a partner. In practical terms, § 707(a)(2)(A) treats certain partnership allocations as disguised payments for services, subjecting them to ordinary income treatment rather than the favorable treatment that might otherwise apply to partnership allocations.

Treasury Regulation § 1.707-2 implements IRC § 707(a)(2)(A) and sets forth a six-factor test for determining whether an arrangement between a partner and a partnership constitutes a disguised payment for services. The six factors, all of which must be weighed under a facts-and-circumstances analysis, are:

(i) Entrepreneurial risk. Whether the arrangement lacks significant entrepreneurial risk. This is widely considered the most important factor. If the allocation and distribution to the partner are subject to significant entrepreneurial risk — meaning the partner bears a genuine risk that the amounts will fluctuate based on overall partnership profits — the arrangement is less likely to be treated as a disguised payment for services.

(ii) Transitory partner status. Whether the partner holds a transitory partnership interest, or whether the partner's interest is expected to be of short duration and is designed to terminate upon receipt of the distribution.

(iii) Matching of distribution to services. Whether the distribution to the partner is designed to effect a level of compensation that the partner would have received if the allocation and distribution had been structured as a direct payment for services, taking into account the time and nature of the services rendered.

(iv) Relative value of partner's interest. Whether the value of the partner's interest in the partnership is small in relation to the allocation in question. If the allocation is large relative to the partner's ongoing interest in the partnership, this factor weighs in favor of disguised payment treatment.

(v) Certainty of partnership assets. Whether the arrangement provides a high degree of certainty that the partnership will have sufficient net assets available to make the distribution to the partner, regardless of the success of partnership operations.

(vi) Other facts and circumstances. Any other facts and circumstances relevant to the determination of whether the arrangement constitutes a disguised payment for services.

In addition to the regulatory framework, several additional authorities are relevant to the analysis:

IRS Notice 2015-54 is of particular importance. Issued on August 5, 2015, Notice 2015-54 addresses management fee waiver arrangements in the context of investment funds. The Notice states that the IRS and the Treasury Department are aware of arrangements in which a partner in an investment partnership waives its right to receive a fee, typically a management fee, in exchange for an allocation of partnership income or gain that is treated as long-term capital gain. The Notice identifies these arrangements as potentially abusive and announces that the IRS intends to challenge such arrangements under IRC § 707(a)(2)(A) and, where applicable, other provisions of the Code. The Notice specifically focuses on arrangements in which the fee waiver is structured so that the partner bears little or no economic risk with respect to the waived amount — for example, where the waived fee is allocated to a low-risk or guaranteed-return investment tranche.

Revenue Procedure 93-27 and Revenue Procedure 2001-43 provide guidance on the tax treatment of partnership profits interests issued for services. While these revenue procedures are not directly applicable to the management fee waiver issue (because ICM's GP received a capital interest, not a profits interest, in exchange for the waived fee), they provide useful context by establishing the IRS's general framework for distinguishing between service-based and investment-based partnership allocations. The distinction between a profits interest (which generally is not taxable upon receipt under Rev. Proc. 93-27) and a capital interest (which may be taxable upon receipt if it constitutes compensation for services) informs the analysis of whether the fee waiver arrangement should be respected as a genuine investment transaction or recharacterized as disguised compensation.

Relevant case law includes Sol Diamond v. Commissioner, 56 T.C. 530 (1971), which addressed the tax treatment of a profits interest received by a partner in exchange for services. While Sol Diamond predates the enactment of IRC § 707(a)(2)(A), the principles articulated in that case — particularly the emphasis on whether the partner's interest is subject to genuine economic risk — remain relevant to the disguised payment analysis. More recent Tax Court decisions and circuit court authority have continued to apply the Treas. Reg. § 1.707-2 factors, with the "significant entrepreneurial risk" factor consistently identified as the most critical element of the analysis.

C. Risk Assessment

The amount at issue for this issue is $23.8 million, representing the management fee waiver amount that would be recharacterized from capital interest to ordinary income if the IRS prevails.

The potential tax impact of an adverse determination is approximately $4.95 million, calculated as follows:

• Rate differential: $23.8 million × 17% (the difference between the 37% ordinary income rate and the 20% long-term capital gain rate) = $4.046 million.

• Net Investment Income Tax: Under the IRS's position, the recharacterized amount would be subject to NIIT at 3.8% regardless of classification (both ordinary income and net capital gain are subject to NIIT), so the NIIT differential is technically zero. However, if the management fee income were classified as self-employment income rather than investment income, the SE tax implications could differ. For purposes of this preliminary analysis, we note the additional NIIT component of $23.8 million × 3.8% = $904,400 as a potential incremental exposure, resulting in an aggregate estimated tax impact of approximately $4.95 million.

We assess the risk level for this issue as moderate to significant. Several factors contribute to this assessment:

Factors increasing risk:

• IRS Notice 2015-54 specifically targets management fee waiver transactions, signaling that the IRS views these arrangements as a high-priority compliance issue.

• The LB&I Division has established a formal audit campaign directed at fee waiver and conversion structures used by hedge funds and private equity funds. This means that the examining agent is likely to have specialized training and access to campaign-specific audit guidance on this issue.

• The dollar amount at issue ($23.8 million) is substantial, which increases the likelihood that the IRS will devote significant resources to the examination of this issue.

• The management fee waiver arrangement is a recurring structure — the GP has exercised the waiver election in multiple prior tax years, potentially expanding the scope of the examination beyond the 2021 tax year (although the current examination notification covers only 2021).

Factors decreasing risk:

• ICM's waiver arrangement involves genuine downside risk. The GP's waived fees were converted into an unrestricted capital interest subject to the same investment risk as all other partner capital, including the full potential for loss. This is the single most important defensive factor, as the "significant entrepreneurial risk" test under Treas. Reg. § 1.707-2 is widely regarded as the dispositive factor in the disguised payment analysis.

• The waiver election was made prospectively — prior to the beginning of the 2021 fiscal year — rather than retroactively after the investment results for the year were known. A prospective election demonstrates that the GP was accepting genuine uncertainty about the economic outcome of the waiver at the time the election was made.

• The waived amount was treated identically to LP capital — same investment exposure, same liquidity restrictions, same lockup periods, and same position in the distribution waterfall. There was no segregated side pocket, no priority return tranche, and no guaranteed minimum return on the waived capital.

• The LPA provisions governing the waiver mechanism (§ 4.1(c)) are clearly drafted and have been consistently applied in prior years, demonstrating that the arrangement is a bona fide structural feature of the Fund's compensation framework, not an ad hoc tax avoidance strategy.

On balance, while the IRS's heightened focus on fee waiver arrangements creates significant audit risk, the factual characteristics of ICM's structure are distinguishable from the abusive arrangements targeted by Notice 2015-54, and we believe the position is defensible.

D. Preliminary Defense Strategy

Our preliminary defense strategy for Issue 1 is organized around the following elements:

1. Entrepreneurial Risk. The centerpiece of the defense should be a comprehensive factual showing that the GP's waived management fee was converted into an interest bearing significant entrepreneurial risk within the meaning of Treas. Reg. § 1.707-2(b)(1). We will demonstrate that:

(a) The GP's increased capital interest was invested in the same multi-strategy portfolio as all other Fund capital, with no preferential allocation, segregation, or risk mitigation.

(b) The Fund's investment strategies — global macro, event-driven equity, and credit — involve meaningful volatility and the genuine possibility of loss. Historical performance data for the Fund, including periods of negative returns, should be compiled to illustrate the real risk borne by the GP on the waived amount.

(c) The GP's waived capital was subject to the same lockup and liquidity restrictions as limited partner capital, meaning that the GP could not withdraw the waived amount to avoid losses during periods of adverse performance.

2. Prospective Election. We will emphasize that the waiver election was made before the beginning of the 2021 fiscal year, as documented by the GP resolution dated November 18, 2020 and the Venkatesh memorandum dated November 15, 2020. This timing is critical because it demonstrates that the GP accepted the risk of an uncertain investment outcome at the time of the election. A retroactive waiver — made after the GP knew the investment results for the year — would be far more vulnerable to challenge. The prospective nature of ICM's waiver election is one of its strongest defensive features.

3. Consistent Treatment. We will demonstrate that the GP's increased capital interest was treated identically to all other LP capital in the Fund's books, records, and capital account statements maintained by Greystone Fund Administration LLC. This includes consistent application of the distribution waterfall, identical allocation methodology for profits and losses, and no special terms or protections afforded to the waived capital.

4. Distinction from Notice 2015-54 Targeted Arrangements. We will affirmatively distinguish ICM's structure from the types of arrangements identified in Notice 2015-54 as potentially abusive. The Notice specifically targets arrangements in which the waived fee is allocated to a low-risk or guaranteed-return tranche, effectively replicating the economic character of a fee while achieving capital gain treatment. ICM's arrangement does not exhibit these characteristics. The GP's waived capital was not allocated to a priority return tranche, was not subject to a guaranteed minimum return, and was not otherwise structured to minimize the GP's economic risk.

5. Document Assembly. To support the foregoing defense, we will obtain and organize the following documents:

(i) GP resolution dated November 18, 2020 approving the 2021 fee waiver election;

(ii) Priya Venkatesh's contemporaneous memoranda dated November 15, 2020 analyzing and recommending the waiver election;

(iii) LPA § 4.1 (management fee provisions) and § 4.1(c) (waiver mechanism provisions);

(iv) Capital account records from Greystone Fund Administration LLC showing the treatment of the waived amount as a capital contribution, including quarterly capital account statements for the GP;

(v) Fund performance data, including monthly NAV reports, showing the actual investment returns (and risks of loss) borne by the GP's increased capital interest during 2021;

(vi) Historical performance data for prior years in which the GP exercised the waiver election, to demonstrate the genuine variability of investment outcomes; and

(vii) Correspondence or internal memoranda evidencing the business rationale for the waiver election (e.g., alignment of GP and LP interests, reinvestment of fees to demonstrate confidence in the Fund's strategy).

V. Issue 2: Carried Interest Holding Period — IRC § 1061

A. Factual Background

For the tax year ended December 31, 2021, total performance allocations to Ironside Capital GP LLC were $94.3 million, as reflected on the GP's Schedule K-1. These performance allocations represent the GP's carried interest — its 20% share of net profits in excess of the 8% preferred return hurdle, as provided in LPA § 5.2.

Of the $94.3 million in total performance allocations, the IRS is expected to challenge $38.7 million, questioning whether the underlying positions attributable to this portion of the allocation satisfy the three-year holding period requirement imposed by IRC § 1061 for long-term capital gain treatment on gains with respect to "applicable partnership interests" ("APIs"). Specifically, the IRS is likely to focus on 14 positions that were liquidated (i.e., sold or otherwise disposed of) during the 2021 calendar year. The IRS's anticipated theory is that some or all of these 14 positions were held for three years or less, and that the corresponding gains should therefore be recharacterized from long-term capital gain to short-term capital gain under the § 1061 regime.

On its 2021 Form 1065, ICM reported all $38.7 million attributable to the 14 challenged positions as long-term capital gain allocated to the GP through the performance allocation. The Fund's position is that all 14 positions satisfied the three-year holding period requirement, based on the acquisition and disposition dates reflected in the Fund's internal records and the records maintained by Ridgeline Securities LLC, the Fund's prime broker.

We have not yet completed a detailed review of the trade-level records for each of the 14 positions. This review is a priority action item, as discussed in Section VIII below. Our preliminary assessment, based on conversations with Marcus Trent and a high-level review of the Fund's investment activity, is that the positions at issue are primarily event-driven equity and credit positions that were acquired in 2017 and 2018, well before the three-year lookback date relative to their 2021 disposition dates. However, we have identified a small number of positions where the holding period may be close to the three-year threshold, and these positions will require particularly careful documentation.

B. Applicable Legal Authority

IRC § 1061 was enacted by the Tax Cuts and Jobs Act of 2017, effective for taxable years beginning after December 31, 2017. Section 1061 provides that, notwithstanding the general one-year holding period for long-term capital gain treatment under IRC § 1222, net long-term capital gain with respect to an "applicable partnership interest" ("API") held by a taxpayer shall be treated as short-term capital gain to the extent such gain is attributable to assets held for three years or less.

The purpose of § 1061 is to address the so-called "carried interest" provision — the favorable tax treatment of performance-based compensation paid to investment fund managers in the form of partnership profit allocations. Prior to the enactment of § 1061, a fund manager's carried interest could generate long-term capital gain on assets held for more than one year, even though the carried interest was received in connection with the manager's services. Section 1061 extends the required holding period for long-term capital gain treatment from one year to three years for gains with respect to APIs, effectively requiring fund managers to hold the underlying assets for a longer period to qualify for favorable capital gain rates.

IRC § 1061(c) defines "applicable partnership interest" as any interest in a partnership which is transferred to (or is held by) the taxpayer in connection with the performance of substantial services by the taxpayer, or any other related person, in any "applicable trade or business." An "applicable trade or business" is defined as any activity conducted on a regular, continuous, and substantial basis which consists, in whole or in part, of (i) raising or returning capital, and (ii) either (A) investing in (or disposing of) specified assets (or identifying specified assets for such investing or disposition), or (B) developing specified assets. "Specified assets" include securities, commodities, real estate held for rental or investment, cash or cash equivalents, options or derivative contracts with respect to any of the foregoing, and an interest in a partnership to the extent of the partnership's proportionate interest in any of the foregoing.

It is clear that ICM's GP holds an API within the meaning of § 1061(c). Ironside Capital GP LLC receives its carried interest in connection with its performance of investment management services for the Fund, which constitutes an "applicable trade or business" involving the raising of capital and the investing in and disposing of specified assets (securities, commodities, and derivatives).

Treasury Regulations §§ 1.1061-1 through 1.1061-6, finalized in January 2021, provide the detailed mechanics for implementing the three-year holding period test. The regulations introduce the concepts of the "One Year Disposition Amount" (the amount of net capital gain from the disposition of assets held for more than one year but not more than three years) and the "Three Year Disposition Amount" (the amount of net capital gain from the disposition of assets held for more than three years). The difference between the One Year Disposition Amount and the Three Year Disposition Amount represents the amount of gain that must be recharacterized from long-term capital gain to short-term capital gain under § 1061.

IRC § 1061(d) addresses the transfer of an API, providing that gain from the transfer of an API is treated as short-term capital gain to the extent of the transferring partner's distributive share of gain attributable to assets held for less than three years. This provision is not directly implicated in the current examination, as the issue concerns the disposition of underlying fund assets, not the transfer of the GP's partnership interest itself.

C. Risk Assessment

The amount at issue for this issue is $38.7 million, representing the portion of the GP's performance allocation that the IRS is expected to challenge.

The potential tax impact of an adverse determination is approximately $6.579 million, calculated as the $38.7 million recharacterization amount multiplied by the 17% rate differential between the ordinary income/short-term capital gain rate (37%) and the long-term capital gain rate (20%). This calculation assumes that the recharacterized gain would be taxed at the maximum ordinary income rate applicable to the GP's managing members. The NIIT at 3.8% would apply regardless of the gain's characterization (both long-term and short-term capital gain are subject to NIIT), so there is no incremental NIIT exposure from the recharacterization.

We assess the risk level for this issue as low to moderate, provided that trade-level documentation supports the holding period for all 14 positions. The critical observation is that this issue presents no legal ambiguity — the three-year holding period requirement under IRC § 1061 is straightforward and mechanically applied. The only question is whether the factual records demonstrate that each of the 14 positions was held for more than three years. If the acquisition and disposition dates for all 14 positions are clearly documented and show a holding period in excess of three years, the IRS has no basis for adjustment.

The risk is elevated to "moderate" by two considerations:

(i) Documentation risk. If any of the 14 positions was acquired through multiple lots over time (a common practice for an event-driven equity or credit strategy), the question of which specific lots were sold becomes relevant. The Fund must demonstrate that the specific lots sold in 2021 were acquired more than three years prior, which requires clear documentation of the specific identification or FIFO methodology used to identify the disposed lots.

(ii) Positions near the threshold. If any of the 14 positions was acquired close to three years before its disposition date, the IRS may scrutinize the acquisition date with particular care, potentially challenging the trade date versus settlement date used for holding period purposes or questioning whether the position was truly acquired on the stated date.

Notwithstanding these considerations, we believe this issue is fundamentally a documentation exercise, and the risk is manageable with proper preparation.

D. Preliminary Defense Strategy

Our preliminary defense strategy for Issue 2 is focused on assembling and presenting comprehensive trade-level documentation for all 14 positions:

1. Position-Level Holding Period Analysis. We will compile a detailed holding period analysis for each of the 14 positions at issue. For each position, the analysis will include:

(a) Security identification (name, CUSIP/ISIN, ticker symbol);

(b) Acquisition date(s) (trade date and settlement date);

(d) Disposition date(s) (trade date and settlement date);

(e) Disposition proceeds;

(f) Holding period in calendar days (calculated from trade date to trade date and from settlement date to settlement date);

(g) Gain or loss amount; and

(h) Classification as long-term or short-term capital gain/loss under both the standard one-year test (IRC § 1222) and the three-year test (IRC § 1061).

2. Cross-Reference with Prime Broker Records. For each of the 14 positions, we will obtain and cross-reference the acquisition and disposition dates against the official trade confirmations and account statements maintained by Ridgeline Securities LLC. Ridgeline's records are independent of the Fund's internal records and will provide corroborating evidence of the holding periods. Any discrepancies between the Fund's internal records and Ridgeline's records must be identified and resolved before the analysis is presented to the IRS.

3. Coordination with Borwick Craine & Associates LLP. We will obtain the holding period workpapers and gain/loss calculations prepared by Borwick Craine & Associates LLP (specifically, Elliot Navarro, tax engagement partner) in connection with the preparation of the 2021 Form 1065 and related Schedules K-1. These workpapers should document the methodology used to calculate holding periods and classify gains, and will serve as the foundation for our analysis.

4. Fund Administrator Records. We will request trade blotters, execution records, and settlement statements from Greystone Fund Administration LLC to provide an additional layer of documentation. Although the fund administrator's records are generally derived from the prime broker's records, they represent an independent source that can corroborate the holding period data.

5. Lot Identification Methodology. For positions that were acquired through multiple lots over time, we will confirm that the Fund properly applied a specific identification or first-in, first-out ("FIFO") methodology to identify the lots disposed of in 2021. If specific identification was used, we will obtain the contemporaneous lot identification records (e.g., internal trade tickets, investment committee memoranda, or instructions to the prime broker specifying which lots were to be sold). If FIFO was used, we will confirm that the methodology was consistently applied across all positions.

6. Presentation to the IRS. We will prepare the holding period analysis in spreadsheet format, with supporting source documents organized by position, suitable for presentation to Revenue Agent Albrecht in response to any IDR targeting this issue. A clear, well-organized presentation will facilitate efficient resolution and minimize the risk of protracted examination.

7. Positions Near the Three-Year Threshold. For any positions where the holding period is close to the three-year threshold (e.g., positions acquired within a few weeks of the three-year lookback date), we will ensure that the supporting documentation is particularly robust and unambiguous. If the trade date versus settlement date distinction could affect the holding period classification for any position, we will analyze the applicable authority on the proper date for measuring the holding period and prepare a memorandum addressing this point.

Robert Jansen will lead the preparation of the trade-level holding period analysis upon receipt of the trade confirmations from Ridgeline Securities LLC.

VI. Issue 3: Organizational and Syndication Cost Deductions — IRC §§ 709 and 195

A. Factual Background

On its 2021 Form 1065, ICM deducted a total of $1.42 million under IRC § 709(b) as amortized organizational expenses. These expenses relate to costs incurred in connection with the Fund's formation in 2016 and have been amortized ratably over a 180-month period beginning with the month in which the Fund commenced business (June 2016). The 2021 deduction represents the sixth year of amortization under the § 709(b) election.

The IRS is expected to challenge $680,000 of the $1.42 million total deduction, arguing that this portion of the costs was improperly classified as deductible organizational expenses when it should have been classified as non-deductible, non-amortizable syndication costs. If the IRS prevails on this reclassification, the $680,000 would be permanently capitalized with no recovery through amortization or any other deduction.

The distinction between organizational expenses and syndication costs is well-established under the Code and regulations but frequently gives rise to disputes, particularly in the context of investment fund formations where a single law firm or accounting firm may perform both types of work during a single engagement. The classification of each expense depends on the nature of the underlying services, not on the identity of the service provider or the form of the invoice.

Organizational expenses, eligible for amortization under IRC § 709(b), are expenses that are (i) incident to the creation of the partnership, (ii) chargeable to capital account, and (iii) of a character that, if expended incident to the creation of a partnership having an ascertainable life, would be amortizable over such life. Typical examples include legal fees for drafting the partnership agreement, accounting fees for establishing the partnership's initial accounting system, and filing fees paid to the state of formation.

Syndication costs, which are permanently non-deductible under IRC § 709(a), are expenses connected with the issuance and marketing of partnership interests. Typical examples include printing costs for offering materials, brokerage fees and placement agent commissions, registration fees, legal fees for preparing securities law opinions and private placement memoranda, and accounting fees for preparing financial projections or other materials for prospective investors.

The $680,000 at issue appears to consist primarily of legal fees incurred during the Fund's 2016 formation. Based on our preliminary review, these fees were paid to the law firm or firms that handled the Fund's formation, and the invoices may cover a range of services including both partnership agreement drafting (organizational) and private placement memorandum preparation (syndication). The critical question is whether the $680,000 in challenged expenses can be shown to relate to organizational activities (partnership formation, LPA drafting, structural advice) rather than syndication activities (investor marketing, offering document preparation, securities law compliance).

B. Applicable Legal Authority

IRC § 709(a) provides the general rule that no deduction shall be allowed for amounts paid or incurred to organize a partnership or to promote the sale of (or to sell) an interest in such partnership (i.e., syndication costs). This blanket disallowance applies to both current deductions and amortization — syndication costs may not be deducted or amortized under any provision of the Code.

IRC § 709(b) creates a limited exception to the § 709(a) disallowance by permitting a partnership to elect to amortize organizational expenses over a period of not less than 180 months, beginning with the month in which the partnership begins business. In addition, a partnership may elect to deduct up to $5,000 of organizational expenses in its first taxable year, with the $5,000 amount reduced dollar-for-dollar to the extent that total organizational expenses exceed $50,000.

IRC § 195 addresses start-up expenditures, which constitute a third category of pre-opening costs that is conceptually distinct from both organizational expenses and syndication costs. Start-up expenditures are costs that would be deductible as ordinary and necessary business expenses under IRC § 162 if incurred in connection with an existing active trade or business, but that are incurred before the partnership's business begins. While § 195 is less directly relevant to this issue, the IRS may attempt to argue that certain expenses classified by ICM as organizational expenses are more properly characterized as start-up expenditures (which are subject to a similar but separately administered amortization regime) or as syndication costs (which are permanently non-deductible).

Treasury Regulation § 1.709-2(a) provides a detailed definition of organizational expenses, including the following examples: legal fees for negotiation and preparation of a partnership agreement, accounting fees for services incident to the organization of the partnership, and filing fees paid to governmental agencies. The regulation emphasizes that the expense must be "incident to the creation" of the partnership and "chargeable to capital account."

Treasury Regulation § 1.709-2(b) defines syndication costs with corresponding specificity, providing the following examples: brokerage fees, registration fees, legal fees of the underwriter or placement agent and the issuer for securities advice and for preparation of the prospectus or private placement memorandum, printing costs of the prospectus, selling and promotional material, and other selling and promotional expenses. The regulation also states that syndication costs include accounting fees for preparation of representations to be included in the offering materials.

The key analytical distinction between organizational expenses and syndication costs turns on the purpose of the expenditure: whether the expense relates to creating the partnership entity and establishing its governance structure (organizational) or to marketing and selling partnership interests to investors (syndication). In many fund formation engagements, these two categories of work are performed concurrently by the same professionals, making the classification exercise inherently factual and dependent on the granularity of the underlying time records and invoices.

C. Risk Assessment

The amount at issue for this issue is $680,000, representing the portion of the amortized organizational expense deduction that the IRS is expected to reclassify as non-deductible syndication costs.

The potential tax impact of an adverse determination is approximately $251,600, calculated as $680,000 multiplied by the top marginal ordinary income rate of 37%. This impact is borne proportionally across all partners through the partnership in proportion to their respective allocable shares. Of the three issues under examination, this issue involves the smallest dollar amount and the most limited tax exposure.

We assess the risk level for this issue as low to moderate. The characterization question is inherently factual, and the outcome depends almost entirely on the nature of the underlying services reflected in the formation-era invoices. If the invoices from the law firm(s) that handled ICM's 2016 formation are sufficiently detailed — with line-item descriptions and time entries that clearly distinguish between partnership agreement drafting (organizational) and private placement memorandum/offering document preparation (syndication) — the IRS challenge can be rebutted by demonstrating that the $680,000 at issue relates exclusively to organizational activities.

However, a significant complication exists: legal fees for fund formation work frequently involve blended tasks. It is common for a single attorney to work on both the limited partnership agreement and the private placement memorandum during the same time period, and for invoices to reflect aggregate time entries covering both types of work. If the invoices from ICM's formation counsel lack sufficient granularity to parse organizational from syndication activities on a line-by-line basis, the IRS may argue that the insufficiently documented expenses should default to syndication treatment, relying on the principle that the taxpayer bears the burden of substantiating the deductibility of claimed expenses.

An additional risk factor is that the IRS has historically taken an aggressive position on the organizational/syndication distinction, particularly in the context of investment fund formations. IRS examiners may argue that the majority of legal work performed during a fund's formation relates to the marketing and sale of partnership interests (syndication), with only a relatively small portion attributable to the creation of the partnership entity itself (organizational). This argument has some intuitive appeal in the hedge fund context, where the economic purpose of the formation is to raise capital from investors, and the partnership agreement is in many respects a marketing document as much as an organizational one.

Notwithstanding these risks, the dollar amount at issue is relatively modest, and we believe the position is defensible with adequate documentation.

D. Preliminary Defense Strategy

Our preliminary defense strategy for Issue 3 is organized around the following elements:

1. Invoice Review and Analysis. The first and most important step is to obtain the original legal invoices from the law firm or firms that handled ICM's 2016 formation. We will identify which firm or firms performed the formation work and whether the invoices include detailed time entries that distinguish between partnership agreement drafting and structuring (organizational) and private placement memorandum preparation and securities law compliance (syndication).

2. Formation-Era Documentation. We will obtain the Ironside Capital GP LLC board resolutions from 2016 relating to the Fund's formation and initial capital raise. These resolutions may provide useful context regarding the nature and scope of the legal work commissioned by the GP in connection with the formation.

3. Fenwick Craine Workpapers. We will review the workpapers prepared by Borwick Craine & Associates LLP (Sandra Whitmore, audit engagement partner; Elliot Navarro, tax engagement partner) in connection with the original classification of organizational and syndication costs on the 2016 Form 1065 and the computation of amortization schedules through the 2021 return. These workpapers should document the methodology and rationale used to allocate formation-era expenses between the two categories.

4. Allocation Schedule. If the invoices are sufficiently detailed, we will prepare a comprehensive allocation schedule that maps each invoice line item to either the organizational or syndication category, with supporting rationale for each classification. This schedule should be structured so that it can be presented to the IRS in response to an IDR or during an examination conference.

5. Supplemental Evidence. If the invoices lack sufficient granularity to support a line-by-line allocation, we will consider obtaining affidavits or declarations from the attorneys who performed the formation work. These declarations would describe the nature of the services rendered, the approximate time spent on organizational versus syndication activities, and the basis for the classification of each category of expense. While such after-the-fact evidence is inherently less persuasive than contemporaneous documentation, it may be necessary to fill gaps in the invoice record.

6. Substantive Argument. On the merits, we will argue that the $680,000 at issue relates to partnership agreement negotiation, amendment, and structuring — work that is directly "incident to the creation of the partnership" within the meaning of Treas. Reg. § 1.709-2(a) and therefore constitutes an organizational expense eligible for amortization under IRC § 709(b). We will distinguish this work from the preparation of the private placement memorandum, subscription agreements, and investor marketing materials, which ICM has properly classified as syndication costs. To the extent that the GP retained separate counsel or separate engagement teams for organizational and syndication work, this distinction will be easier to demonstrate.

VII. Aggregate Exposure Summary

A. Partnership-Level Adjustment Amounts

The following table summarizes the potential partnership-level adjustments across all three issues:

B. Estimated Tax Impact

The following table summarizes the estimated tax impact of an adverse determination on each issue, calculated across all affected partners:

These estimates are preliminary and are based on the assumption that all affected partners are subject to the maximum marginal tax rates. Actual tax impact will vary based on individual partner circumstances, including the tax-exempt status of certain institutional investors (e.g., Northgate Public Employees' Retirement System), the availability of offsetting losses or credits, and the application of state and local income taxes.

Under the BBA centralized audit regime, the partnership-level "imputed underpayment" computation may differ from the aggregate partner-level tax impact, as the imputed underpayment is calculated using the highest applicable rate without regard to individual partner circumstances. The availability of modification procedures under IRC § 6225(c) — including the "amended return" modification, the "tax-exempt partner" modification, and the "rate modification" — could significantly reduce the imputed underpayment if the examination results in a notice of proposed partnership adjustment ("NOPPA"). We will analyze the potential benefits of these modification procedures in greater detail as the examination progresses.

C. Risk Ranking

Based on our preliminary analysis, we rank the three issues as follows in order of decreasing risk:

Issue 1 — Management Fee Waiver (IRC § 707(a)(2)(A)): Moderate to significant risk. This issue presents the greatest legal complexity and the highest audit priority for the IRS, given the LB&I Division's targeted campaign against fee waiver and conversion structures. However, the factual profile of ICM's arrangement — involving genuine downside risk, prospective election, and no preferential return — distinguishes it from the abusive structures targeted by IRS Notice 2015-54 and provides a strong foundation for defense. The estimated tax exposure is approximately $4.95 million.

Issue 2 — Carried Interest Holding Period (I

PRIVILEGED AND CONFIDENTIAL — ATTORNEY WORK PRODUCT — ATTORNEY-CLIENT PRIVILEGE This memorandum is protected by the attorney-client privilege and the work product doctrine. It contains confidential attorney mental impressions, conclusions, opinions, and legal theories. It is intended solely for the use of attorneys and personnel of Calderwood & Harkness LLP engaged on this matter and the client. No portion of this memorandum may be disclosed to any third party without the express written consent of Calderwood & Harkness LLP.
CALDERWOOD & HARKNESS LLP 1251 Avenue of the Americas, 40th Floor New York, New York 10020 Telephone: (212) 558-4000 Facsimile: (212) 558-3588
INTERNAL MEMORANDUM
April 21, 2023
TO: Sylvia Hartwell, Partner, Tax Department
FROM: Leila Nazari, Associate, Tax Department Robert Jansen, Associate, Tax Department
RE: Preliminary Issue Analysis and Defense Strategy — IRS Examination of Ironside Capital Management LP (EIN 83-2741956), Form 1065, Tax Year Ended December 31, 2021
MATTER NO.: 1023-00003
I. Executive Summary
Calderwood & Harkness LLP was engaged on April 10, 2023 to represent Ironside Capital Management LP ("ICM" or the "Fund"), a Delaware limited partnership (EIN 83-2741956) headquartered at 590 Madison Avenue, 28th Floor, New York, New York 10022, in connection with an IRS Large Business & International Division ("LB&I") examination of ICM's 2021 partnership tax return (Form 1065), which was filed on extension on September 15, 2022 by Borwick Craine & Associates LLP, ICM's outside auditor and tax return preparer.
The examination was initiated by IRS Letter 2205-D dated March 22, 2023, which was received by ICM on March 29, 2023. The examination has been assigned to the Pass-Through Entities Practice Area of the LB&I Division at the IRS Manhattan Campus, located at 290 Broadway, New York, New York 10007. The lead examiner is Revenue Agent Timothy J. Albrecht (GS-13, Badge No. 74-28193), with supporting agent Dawn M. Petrovic (GS-12). The territory manager overseeing the examination is Karen P. Driscoll.
Upon engagement, the firm promptly filed Form 2848 (Power of Attorney and Declaration of Representative) on April 14, 2023, designating Sylvia Hartwell and Leila Nazari as authorized representatives of ICM before the Internal Revenue Service. This designation ensures that all IRS communications related to the examination will be directed to the firm rather than to the client directly, allowing us to maintain control over the flow of information and the development of the defense strategy.
The firm was initially contacted on April 5, 2023 by Marcus Trent, General Counsel of ICM, who serves as the primary client liaison for this matter. Mr. Trent has been cooperative and responsive to date and has expressed a willingness to make ICM's personnel, records, and third-party service providers available as needed for the defense.
Based on our initial review of the 2021 Form 1065, the underlying workpapers prepared by Borwick Craine & Associates LLP, and the ICM Limited Partnership Agreement dated June 14, 2016 (as amended through the Fourth Amendment dated March 1, 2020) (collectively, the "LPA"), we have identified three primary issues that the IRS is likely to examine during the course of this audit. These issues align with known LB&I campaign priorities targeting hedge fund and private equity fee structures, as well as with scope indicators discernible from the examination notification letter. This memorandum provides a preliminary analysis of each issue, quantifies the potential exposure at both the partnership and partner levels, and recommends a comprehensive defense strategy.
The total potential partnership-level adjustment across all three issues is approximately $63.18 million. The estimated aggregate tax impact across all partners, taking into account applicable rate differentials, is approximately $11.78 million. While this aggregate exposure is substantial, we believe that all three positions taken on ICM's 2021 Form 1065 are defensible, provided that adequate documentation can be assembled and well-supported legal arguments are presented to the examining agents. The strength of the defense varies by issue, as detailed below, but none of the three issues presents an exposure that, in our preliminary judgment, would warrant concession at this stage.
This memorandum is intended to serve as a working document to guide the defense strategy. It will be updated as the examination progresses, as we receive and review additional documents from the client and third-party service providers, and as the IRS clarifies its areas of focus through the issuance of Information Document Requests and other examination activity.
II. Client and Fund Overview
A. Entity Structure
Ironside Capital Management LP is a Delaware limited partnership formed on June 14, 2016 pursuant to a Certificate of Limited Partnership filed with the Delaware Secretary of State. ICM's registered agent in Delaware is Capitol Statutory Services LLC, located at 1209 Orange Street, Wilmington, Delaware 19801. ICM maintains its principal office at 590 Madison Avenue, 28th Floor, New York, New York 10022, and is registered to do business in the State of New York.
The general partner of ICM is Ironside Capital GP LLC, a Delaware limited liability company (EIN 83-2741890), which was also formed on June 14, 2016. Ironside Capital GP LLC is the sole general partner of ICM and is responsible for the management, control, and operation of the Fund's business, including all investment decisions, in accordance with the terms of the LPA.
The managing members of Ironside Capital GP LLC are as follows:
• Desmond R. Calloway — Founder and Chief Investment Officer. Mr. Calloway holds a 62% membership interest in Ironside Capital GP LLC. As of December 31, 2021, his capital account in ICM (inclusive of amounts attributable to his interest in the GP and any direct investment) was approximately $187.4 million. Mr. Calloway is ultimately responsible for all portfolio management and investment strategy decisions.
• Priya Venkatesh — Chief Operating Officer and Chief Financial Officer. Ms. Venkatesh holds a 28% membership interest in Ironside Capital GP LLC. As of December 31, 2021, her capital account in ICM was approximately $48.6 million. Ms. Venkatesh oversees the Fund's operations, financial reporting, compliance, and relationships with service providers, including the fund administrator, prime broker, and outside auditors.
• Other GP Members — The remaining 10% membership interest in Ironside Capital GP LLC is held by other members of the GP entity, whose identities and interests are not material to the issues under examination and are not discussed in detail in this memorandum.
The partnership structure of ICM is a standard two-tier hedge fund structure, with investors (limited partners) making capital commitments to the Fund, and the GP managing the Fund in exchange for management fees and performance-based allocations (carried interest). There are no blocker entities or feeder funds that are relevant to the current examination, although we note that certain limited partners invest through their own tiered structures, which increases the total number of Schedule K-1s issued by the Fund beyond the number of direct partners.
B. Fund Operations and Financials (Tax Year 2021)
ICM operates as a multi-strategy hedge fund, deploying capital across three principal investment strategies: (i) global macro, encompassing positions in sovereign debt, currencies, commodities, and macroeconomic derivatives; (ii) event-driven equity, focused on corporate events such as mergers, acquisitions, restructurings, and spin-offs; and (iii) credit strategies, including distressed debt, structured credit, and high-yield fixed income. The multi-strategy approach is designed to generate risk-adjusted returns across a range of market environments while providing diversification benefits to the portfolio.
As of December 31, 2021, ICM's total assets under management ("AUM") were approximately $3.82 billion, as reported on ICM's 2021 Form 1065, Schedule L (Balance Sheets per Books). This figure reflects the aggregate net asset value of the Fund's portfolio, inclusive of all investment positions, cash, and other assets, net of liabilities.
The Fund had a total of 47 limited partners as of December 31, 2021, plus the general partner. The limited partner base consists of a mix of institutional investors, family offices, endowments, and high-net-worth individuals. Key limited partners referenced in the course of our initial review include:
• Northgate Public Employees' Retirement System — a public pension fund with a capital commitment to ICM of approximately $412 million, making it the Fund's largest single investor by committed capital.
• Bramblewood Family Office LLC — a private family office with a capital commitment of approximately $95 million.
• Marlowe Asset Management Horizon Endowment Fund — a university endowment fund with a capital commitment of approximately $175 million.
These investors are identified here for context only; their individual tax situations are not directly at issue in the partnership-level examination, although any partnership-level adjustments will flow through to their respective Schedules K-1 pursuant to the Bipartisan Budget Act partnership audit rules.
The Fund's compensation structure for the GP is as follows:
Management Fee. Pursuant to LPA § 4.1, the GP is entitled to an annual management fee equal to 2% of committed capital. For the tax year ended December 31, 2021, average committed capital was approximately $3.58 billion, resulting in total management fees of approximately $71.6 million ($3.58 billion × 2%). The management fee is paid quarterly in advance, calculated as one-quarter of the annual rate applied to committed capital as of the first business day of each quarter, subject to certain adjustments specified in the LPA.
Carried Interest (Performance Allocation). Pursuant to LPA § 5.2, the GP is entitled to a performance allocation equal to 20% of the net profits of the Fund in excess of an 8% preferred return hurdle (the "Hurdle Rate"), with a full catch-up provision allowing the GP to receive 100% of profits above the Hurdle Rate until the GP has received its full 20% allocation of cumulative profits. For the tax year ended December 31, 2021, total performance allocations to the GP were approximately $94.3 million, as reported on the Schedule K-1 issued to Ironside Capital GP LLC. Based on the Fund's AUM and these performance figures, the implied gross fund return for 2021 was approximately 18.7%, substantially exceeding the 8% Hurdle Rate and triggering the full catch-up and carried interest allocation.
The Fund's principal third-party service providers relevant to this engagement are:
• Fund Administrator: Greystone Fund Administration LLC. Greystone is responsible for the Fund's net asset value calculations, capital account maintenance, management fee and performance allocation computations, investor reporting, and financial statement preparation.
• Prime Broker: Ridgeline Securities LLC. Ridgeline provides trade execution, clearing, settlement, custody, and securities lending services to the Fund. Ridgeline maintains the official trade records, account statements, and trade confirmations that will be central to the defense of Issue 2 (carried interest holding period).
• Auditor and Tax Return Preparer: Borwick Craine & Associates LLP. Fenwick Craine serves as the Fund's independent auditor and also prepares the Fund's annual partnership tax return (Form 1065) and all related Schedules K-1. The audit engagement partner is Sandra Whitmore, CPA, and the tax engagement partner is Elliot Navarro, CPA. Fenwick Craine's office is located at 3 World Financial Center, Suite 2400, New York, New York 10281. As the return preparer and auditor, Fenwick Craine will be a critical source of workpapers and supporting documentation for all three issues under examination.
III. Examination Scope and Status
As of the date of this memorandum, the IRS has not yet issued its first Information Document Request ("IDR"). Based on our experience with LB&I examinations of this nature and the timeline typically followed by examiners at the Manhattan Campus, we anticipate receiving IDR #1 within the next one to two weeks. We expect that IDR #1 will be a general books-and-records request, seeking the Fund's complete partnership return, supporting schedules, financial statements, LPA, organizational documents, and related materials. Subsequent IDRs will likely become more targeted as the examination progresses and Revenue Agent Albrecht identifies specific areas of inquiry.
Based on the Letter 2205-D and our initial correspondence with the IRS, the examination is focused on partnership-level items. Under the centralized partnership audit rules enacted by the Bipartisan Budget Act of 2015 ("BBA"), codified at IRC §§ 6221 through 6241, ICM is subject to the partnership-level examination and adjustment regime for its 2021 tax year. No election out of the BBA rules was made under IRC § 6221(b), as the Fund is ineligible for such an election: when tiered partner structures are taken into account, the Fund effectively issues more than 100 Schedules K-1, exceeding the statutory threshold. Marcus Trent, ICM's General Counsel, has been designated as the "partnership representative" within the meaning of IRC § 6223, and he has designated Sylvia Hartwell as the partnership representative's authorized designee.
The BBA framework has significant procedural and substantive implications for the defense strategy. Under the BBA, any imputed underpayment resulting from a partnership-level adjustment is assessed and collected at the partnership level, unless the partnership elects under IRC § 6226 to push out the adjustments to its partners. We will need to evaluate the relative advantages and disadvantages of a push-out election as the examination progresses, taking into account the composition of the partner base, the tax-exempt or reduced-rate status of certain partners (such as Northgate Public Employees' Retirement System), and the availability of modification procedures under IRC § 6225(c) that could reduce any imputed underpayment.
Based on the scope indicators in the notification letter, the IRS's known audit campaigns targeting hedge fund and private equity fee arrangements, and our substantive review of the return, we anticipate three principal examination issues:
1. Management Fee Waiver / Conversion — Whether Ironside Capital GP LLC's waiver of $23.8 million in management fees in exchange for an increased capital interest constitutes a disguised payment for services under IRC § 707(a)(2)(A).
2. Carried Interest Holding Period — Whether $38.7 million of performance allocations to the GP, attributable to 14 liquidated positions, satisfies the three-year holding period requirement under IRC § 1061 for long-term capital gain treatment on applicable partnership interests.
3. Organizational and Syndication Cost Deductions — Whether $680,000 of expenses deducted (as amortized organizational expenses under IRC § 709(b)) should instead be classified as non-deductible, non-amortizable syndication costs under IRC § 709(a).
Each of these issues is analyzed in detail in Sections IV through VI below.
IV. Issue 1: Management Fee Waiver / Conversion — IRC § 707(a)(2)(A)
A. Factual Background
In the tax year ended December 31, 2021, Ironside Capital GP LLC exercised its right under LPA § 4.1(c) to waive a portion of its management fee entitlement in exchange for an increased capital interest in the Fund. Specifically, the GP waived $23.8 million of its total $71.6 million management fee entitlement for 2021. The remaining $47.8 million in management fees was received by the GP in the ordinary course and reported as ordinary income on the Fund's Form 1065 and the GP's Schedule K-1.
The economic effect of the waiver was to convert what would otherwise have been ordinary income — management fees taxable at the top marginal ordinary income rate of 37%, plus the 3.8% Net Investment Income Tax ("NIIT") under IRC § 1411, for a combined rate of 40.8% — into a capital interest in the Fund. That capital interest, upon subsequent appreciation and disposition, would generate long-term capital gain taxable at a combined rate of 23.8% (20% plus 3.8% NIIT), representing a rate differential of approximately 17 percentage points.
The waiver was effected pursuant to a specific mechanism set forth in LPA § 4.1(c), which provides that the GP may elect, prior to the beginning of each fiscal year, to waive all or a portion of its management fee for the upcoming fiscal year in exchange for an equivalent increase in its capital account. Under the terms of the LPA, such waiver is treated as a capital contribution by the GP to the Fund in an amount equal to the waived fee. The LPA expressly states that the increased capital interest resulting from the waiver is treated identically to all other limited partner capital for purposes of investment allocation, liquidity restrictions, and the partnership's distribution waterfall.
Our initial review of the contemporaneous documentation indicates that the waiver election for the 2021 fiscal year was made prior to the beginning of the fiscal year, consistent with the prospective election requirement of LPA § 4.1(c). The documentation supporting the waiver includes:
(i) A resolution of the managing members of Ironside Capital GP LLC, dated November 18, 2020, approving the GP's election to waive $23.8 million of its 2021 management fee entitlement;
(ii) An internal memorandum prepared by Priya Venkatesh, dated November 15, 2020, analyzing the economic and tax implications of the waiver election and recommending the waiver amount; and
(iii) A notification letter from the GP to the Fund Administrator (Greystone Fund Administration LLC), dated December 1, 2020, instructing Greystone to implement the waiver by crediting the GP's capital account with the waived amount ratably over the four quarterly management fee payment dates in 2021.
We have not yet reviewed the complete set of supporting documentation, and one of the action items identified in Section VIII of this memorandum is to obtain and thoroughly review all records related to the waiver election.
The economic substance of the waiver is a critical factual consideration. Under the terms of the LPA, the GP's waived management fees were converted into an unrestricted capital interest in the Fund, subject to the same investment risk, liquidity terms, and allocation methodology as all other partner capital. The waived amount was invested in the Fund's multi-strategy portfolio — the same pool of global macro, event-driven equity, and credit investments in which all limited partner capital is deployed. The GP's increased capital interest was not placed in a segregated side pocket, was not subject to a guaranteed or preferred return, and was not otherwise afforded any form of principal protection or downside mitigation. In short, the GP bore the full risk of loss on the waived amount, just as any other partner would on its committed capital.
This factual point is central to the defense, as discussed in Sections B through D below.
B. Applicable Legal Authority
The primary statutory authority governing this issue is IRC § 707(a)(2)(A), which provides that, if a partner performs services for a partnership, and there is a related direct or indirect allocation and distribution to such partner, and the performance of such services and the allocation and distribution, when viewed together, are properly characterized as a transaction occurring between the partnership and a partner acting other than in his capacity as a member of the partnership, then such transaction shall be treated as a transaction between the partnership and one who is not a partner. In practical terms, § 707(a)(2)(A) treats certain partnership allocations as disguised payments for services, subjecting them to ordinary income treatment rather than the favorable treatment that might otherwise apply to partnership allocations.
Treasury Regulation § 1.707-2 implements IRC § 707(a)(2)(A) and sets forth a six-factor test for determining whether an arrangement between a partner and a partnership constitutes a disguised payment for services. The six factors, all of which must be weighed under a facts-and-circumstances analysis, are:
(i) Entrepreneurial risk. Whether the arrangement lacks significant entrepreneurial risk. This is widely considered the most important factor. If the allocation and distribution to the partner are subject to significant entrepreneurial risk — meaning the partner bears a genuine risk that the amounts will fluctuate based on overall partnership profits — the arrangement is less likely to be treated as a disguised payment for services.
(ii) Transitory partner status. Whether the partner holds a transitory partnership interest, or whether the partner's interest is expected to be of short duration and is designed to terminate upon receipt of the distribution.
(iii) Matching of distribution to services. Whether the distribution to the partner is designed to effect a level of compensation that the partner would have received if the allocation and distribution had been structured as a direct payment for services, taking into account the time and nature of the services rendered.
(iv) Relative value of partner's interest. Whether the value of the partner's interest in the partnership is small in relation to the allocation in question. If the allocation is large relative to the partner's ongoing interest in the partnership, this factor weighs in favor of disguised payment treatment.
(v) Certainty of partnership assets. Whether the arrangement provides a high degree of certainty that the partnership will have sufficient net assets available to make the distribution to the partner, regardless of the success of partnership operations.
(vi) Other facts and circumstances. Any other facts and circumstances relevant to the determination of whether the arrangement constitutes a disguised payment for services.
In addition to the regulatory framework, several additional authorities are relevant to the analysis:
IRS Notice 2015-54 is of particular importance. Issued on August 5, 2015, Notice 2015-54 addresses management fee waiver arrangements in the context of investment funds. The Notice states that the IRS and the Treasury Department are aware of arrangements in which a partner in an investment partnership waives its right to receive a fee, typically a management fee, in exchange for an allocation of partnership income or gain that is treated as long-term capital gain. The Notice identifies these arrangements as potentially abusive and announces that the IRS intends to challenge such arrangements under IRC § 707(a)(2)(A) and, where applicable, other provisions of the Code. The Notice specifically focuses on arrangements in which the fee waiver is structured so that the partner bears little or no economic risk with respect to the waived amount — for example, where the waived fee is allocated to a low-risk or guaranteed-return investment tranche.
Revenue Procedure 93-27 and Revenue Procedure 2001-43 provide guidance on the tax treatment of partnership profits interests issued for services. While these revenue procedures are not directly applicable to the management fee waiver issue (because ICM's GP received a capital interest, not a profits interest, in exchange for the waived fee), they provide useful context by establishing the IRS's general framework for distinguishing between service-based and investment-based partnership allocations. The distinction between a profits interest (which generally is not taxable upon receipt under Rev. Proc. 93-27) and a capital interest (which may be taxable upon receipt if it constitutes compensation for services) informs the analysis of whether the fee waiver arrangement should be respected as a genuine investment transaction or recharacterized as disguised compensation.
Relevant case law includes Sol Diamond v. Commissioner, 56 T.C. 530 (1971), which addressed the tax treatment of a profits interest received by a partner in exchange for services. While Sol Diamond predates the enactment of IRC § 707(a)(2)(A), the principles articulated in that case — particularly the emphasis on whether the partner's interest is subject to genuine economic risk — remain relevant to the disguised payment analysis. More recent Tax Court decisions and circuit court authority have continued to apply the Treas. Reg. § 1.707-2 factors, with the "significant entrepreneurial risk" factor consistently identified as the most critical element of the analysis.
C. Risk Assessment
The amount at issue for this issue is $23.8 million, representing the management fee waiver amount that would be recharacterized from capital interest to ordinary income if the IRS prevails.
The potential tax impact of an adverse determination is approximately $4.95 million, calculated as follows:
• Rate differential: $23.8 million × 17% (the difference between the 37% ordinary income rate and the 20% long-term capital gain rate) = $4.046 million.
• Net Investment Income Tax: Under the IRS's position, the recharacterized amount would be subject to NIIT at 3.8% regardless of classification (both ordinary income and net capital gain are subject to NIIT), so the NIIT differential is technically zero. However, if the management fee income were classified as self-employment income rather than investment income, the SE tax implications could differ. For purposes of this preliminary analysis, we note the additional NIIT component of $23.8 million × 3.8% = $904,400 as a potential incremental exposure, resulting in an aggregate estimated tax impact of approximately $4.95 million.
We assess the risk level for this issue as moderate to significant. Several factors contribute to this assessment:
Factors increasing risk:
• IRS Notice 2015-54 specifically targets management fee waiver transactions, signaling that the IRS views these arrangements as a high-priority compliance issue.
• The LB&I Division has established a formal audit campaign directed at fee waiver and conversion structures used by hedge funds and private equity funds. This means that the examining agent is likely to have specialized training and access to campaign-specific audit guidance on this issue.
• The dollar amount at issue ($23.8 million) is substantial, which increases the likelihood that the IRS will devote significant resources to the examination of this issue.
• The management fee waiver arrangement is a recurring structure — the GP has exercised the waiver election in multiple prior tax years, potentially expanding the scope of the examination beyond the 2021 tax year (although the current examination notification covers only 2021).
Factors decreasing risk:
• ICM's waiver arrangement involves genuine downside risk. The GP's waived fees were converted into an unrestricted capital interest subject to the same investment risk as all other partner capital, including the full potential for loss. This is the single most important defensive factor, as the "significant entrepreneurial risk" test under Treas. Reg. § 1.707-2 is widely regarded as the dispositive factor in the disguised payment analysis.
• The waiver election was made prospectively — prior to the beginning of the 2021 fiscal year — rather than retroactively after the investment results for the year were known. A prospective election demonstrates that the GP was accepting genuine uncertainty about the economic outcome of the waiver at the time the election was made.
• The waived amount was treated identically to LP capital — same investment exposure, same liquidity restrictions, same lockup periods, and same position in the distribution waterfall. There was no segregated side pocket, no priority return tranche, and no guaranteed minimum return on the waived capital.
• The LPA provisions governing the waiver mechanism (§ 4.1(c)) are clearly drafted and have been consistently applied in prior years, demonstrating that the arrangement is a bona fide structural feature of the Fund's compensation framework, not an ad hoc tax avoidance strategy.
On balance, while the IRS's heightened focus on fee waiver arrangements creates significant audit risk, the factual characteristics of ICM's structure are distinguishable from the abusive arrangements targeted by Notice 2015-54, and we believe the position is defensible.
D. Preliminary Defense Strategy
Our preliminary defense strategy for Issue 1 is organized around the following elements:
1. Entrepreneurial Risk. The centerpiece of the defense should be a comprehensive factual showing that the GP's waived management fee was converted into an interest bearing significant entrepreneurial risk within the meaning of Treas. Reg. § 1.707-2(b)(1). We will demonstrate that:
(a) The GP's increased capital interest was invested in the same multi-strategy portfolio as all other Fund capital, with no preferential allocation, segregation, or risk mitigation.
(b) The Fund's investment strategies — global macro, event-driven equity, and credit — involve meaningful volatility and the genuine possibility of loss. Historical performance data for the Fund, including periods of negative returns, should be compiled to illustrate the real risk borne by the GP on the waived amount.
(c) The GP's waived capital was subject to the same lockup and liquidity restrictions as limited partner capital, meaning that the GP could not withdraw the waived amount to avoid losses during periods of adverse performance.
2. Prospective Election. We will emphasize that the waiver election was made before the beginning of the 2021 fiscal year, as documented by the GP resolution dated November 18, 2020 and the Venkatesh memorandum dated November 15, 2020. This timing is critical because it demonstrates that the GP accepted the risk of an uncertain investment outcome at the time of the election. A retroactive waiver — made after the GP knew the investment results for the year — would be far more vulnerable to challenge. The prospective nature of ICM's waiver election is one of its strongest defensive features.
3. Consistent Treatment. We will demonstrate that the GP's increased capital interest was treated identically to all other LP capital in the Fund's books, records, and capital account statements maintained by Greystone Fund Administration LLC. This includes consistent application of the distribution waterfall, identical allocation methodology for profits and losses, and no special terms or protections afforded to the waived capital.
4. Distinction from Notice 2015-54 Targeted Arrangements. We will affirmatively distinguish ICM's structure from the types of arrangements identified in Notice 2015-54 as potentially abusive. The Notice specifically targets arrangements in which the waived fee is allocated to a low-risk or guaranteed-return tranche, effectively replicating the economic character of a fee while achieving capital gain treatment. ICM's arrangement does not exhibit these characteristics. The GP's waived capital was not allocated to a priority return tranche, was not subject to a guaranteed minimum return, and was not otherwise structured to minimize the GP's economic risk.
5. Document Assembly. To support the foregoing defense, we will obtain and organize the following documents:
(i) GP resolution dated November 18, 2020 approving the 2021 fee waiver election;
(ii) Priya Venkatesh's contemporaneous memoranda dated November 15, 2020 analyzing and recommending the waiver election;
(iii) LPA § 4.1 (management fee provisions) and § 4.1(c) (waiver mechanism provisions);
(iv) Capital account records from Greystone Fund Administration LLC showing the treatment of the waived amount as a capital contribution, including quarterly capital account statements for the GP;
(v) Fund performance data, including monthly NAV reports, showing the actual investment returns (and risks of loss) borne by the GP's increased capital interest during 2021;
(vi) Historical performance data for prior years in which the GP exercised the waiver election, to demonstrate the genuine variability of investment outcomes; and
(vii) Correspondence or internal memoranda evidencing the business rationale for the waiver election (e.g., alignment of GP and LP interests, reinvestment of fees to demonstrate confidence in the Fund's strategy).
V. Issue 2: Carried Interest Holding Period — IRC § 1061
A. Factual Background
For the tax year ended December 31, 2021, total performance allocations to Ironside Capital GP LLC were $94.3 million, as reflected on the GP's Schedule K-1. These performance allocations represent the GP's carried interest — its 20% share of net profits in excess of the 8% preferred return hurdle, as provided in LPA § 5.2.
Of the $94.3 million in total performance allocations, the IRS is expected to challenge $38.7 million, questioning whether the underlying positions attributable to this portion of the allocation satisfy the three-year holding period requirement imposed by IRC § 1061 for long-term capital gain treatment on gains with respect to "applicable partnership interests" ("APIs"). Specifically, the IRS is likely to focus on 14 positions that were liquidated (i.e., sold or otherwise disposed of) during the 2021 calendar year. The IRS's anticipated theory is that some or all of these 14 positions were held for three years or less, and that the corresponding gains should therefore be recharacterized from long-term capital gain to short-term capital gain under the § 1061 regime.
On its 2021 Form 1065, ICM reported all $38.7 million attributable to the 14 challenged positions as long-term capital gain allocated to the GP through the performance allocation. The Fund's position is that all 14 positions satisfied the three-year holding period requirement, based on the acquisition and disposition dates reflected in the Fund's internal records and the records maintained by Ridgeline Securities LLC, the Fund's prime broker.
We have not yet completed a detailed review of the trade-level records for each of the 14 positions. This review is a priority action item, as discussed in Section VIII below. Our preliminary assessment, based on conversations with Marcus Trent and a high-level review of the Fund's investment activity, is that the positions at issue are primarily event-driven equity and credit positions that were acquired in 2017 and 2018, well before the three-year lookback date relative to their 2021 disposition dates. However, we have identified a small number of positions where the holding period may be close to the three-year threshold, and these positions will require particularly careful documentation.
B. Applicable Legal Authority
IRC § 1061 was enacted by the Tax Cuts and Jobs Act of 2017, effective for taxable years beginning after December 31, 2017. Section 1061 provides that, notwithstanding the general one-year holding period for long-term capital gain treatment under IRC § 1222, net long-term capital gain with respect to an "applicable partnership interest" ("API") held by a taxpayer shall be treated as short-term capital gain to the extent such gain is attributable to assets held for three years or less.
The purpose of § 1061 is to address the so-called "carried interest" provision — the favorable tax treatment of performance-based compensation paid to investment fund managers in the form of partnership profit allocations. Prior to the enactment of § 1061, a fund manager's carried interest could generate long-term capital gain on assets held for more than one year, even though the carried interest was received in connection with the manager's services. Section 1061 extends the required holding period for long-term capital gain treatment from one year to three years for gains with respect to APIs, effectively requiring fund managers to hold the underlying assets for a longer period to qualify for favorable capital gain rates.
IRC § 1061(c) defines "applicable partnership interest" as any interest in a partnership which is transferred to (or is held by) the taxpayer in connection with the performance of substantial services by the taxpayer, or any other related person, in any "applicable trade or business." An "applicable trade or business" is defined as any activity conducted on a regular, continuous, and substantial basis which consists, in whole or in part, of (i) raising or returning capital, and (ii) either (A) investing in (or disposing of) specified assets (or identifying specified assets for such investing or disposition), or (B) developing specified assets. "Specified assets" include securities, commodities, real estate held for rental or investment, cash or cash equivalents, options or derivative contracts with respect to any of the foregoing, and an interest in a partnership to the extent of the partnership's proportionate interest in any of the foregoing.
It is clear that ICM's GP holds an API within the meaning of § 1061(c). Ironside Capital GP LLC receives its carried interest in connection with its performance of investment management services for the Fund, which constitutes an "applicable trade or business" involving the raising of capital and the investing in and disposing of specified assets (securities, commodities, and derivatives).
Treasury Regulations §§ 1.1061-1 through 1.1061-6, finalized in January 2021, provide the detailed mechanics for implementing the three-year holding period test. The regulations introduce the concepts of the "One Year Disposition Amount" (the amount of net capital gain from the disposition of assets held for more than one year but not more than three years) and the "Three Year Disposition Amount" (the amount of net capital gain from the disposition of assets held for more than three years). The difference between the One Year Disposition Amount and the Three Year Disposition Amount represents the amount of gain that must be recharacterized from long-term capital gain to short-term capital gain under § 1061.
IRC § 1061(d) addresses the transfer of an API, providing that gain from the transfer of an API is treated as short-term capital gain to the extent of the transferring partner's distributive share of gain attributable to assets held for less than three years. This provision is not directly implicated in the current examination, as the issue concerns the disposition of underlying fund assets, not the transfer of the GP's partnership interest itself.
C. Risk Assessment
The amount at issue for this issue is $38.7 million, representing the portion of the GP's performance allocation that the IRS is expected to challenge.
The potential tax impact of an adverse determination is approximately $6.579 million, calculated as the $38.7 million recharacterization amount multiplied by the 17% rate differential between the ordinary income/short-term capital gain rate (37%) and the long-term capital gain rate (20%). This calculation assumes that the recharacterized gain would be taxed at the maximum ordinary income rate applicable to the GP's managing members. The NIIT at 3.8% would apply regardless of the gain's characterization (both long-term and short-term capital gain are subject to NIIT), so there is no incremental NIIT exposure from the recharacterization.
We assess the risk level for this issue as low to moderate, provided that trade-level documentation supports the holding period for all 14 positions. The critical observation is that this issue presents no legal ambiguity — the three-year holding period requirement under IRC § 1061 is straightforward and mechanically applied. The only question is whether the factual records demonstrate that each of the 14 positions was held for more than three years. If the acquisition and disposition dates for all 14 positions are clearly documented and show a holding period in excess of three years, the IRS has no basis for adjustment.
The risk is elevated to "moderate" by two considerations:
(i) Documentation risk. If any of the 14 positions was acquired through multiple lots over time (a common practice for an event-driven equity or credit strategy), the question of which specific lots were sold becomes relevant. The Fund must demonstrate that the specific lots sold in 2021 were acquired more than three years prior, which requires clear documentation of the specific identification or FIFO methodology used to identify the disposed lots.
(ii) Positions near the threshold. If any of the 14 positions was acquired close to three years before its disposition date, the IRS may scrutinize the acquisition date with particular care, potentially challenging the trade date versus settlement date used for holding period purposes or questioning whether the position was truly acquired on the stated date.
Notwithstanding these considerations, we believe this issue is fundamentally a documentation exercise, and the risk is manageable with proper preparation.
D. Preliminary Defense Strategy
Our preliminary defense strategy for Issue 2 is focused on assembling and presenting comprehensive trade-level documentation for all 14 positions:
1. Position-Level Holding Period Analysis. We will compile a detailed holding period analysis for each of the 14 positions at issue. For each position, the analysis will include:
(a) Security identification (name, CUSIP/ISIN, ticker symbol);
(b) Acquisition date(s) (trade date and settlement date);
(c) Acquisition cost basis (including any adjustments for corporate actions, stock splits, or other events);
(d) Disposition date(s) (trade date and settlement date);
(e) Disposition proceeds;
(f) Holding period in calendar days (calculated from trade date to trade date and from settlement date to settlement date);
(g) Gain or loss amount; and
(h) Classification as long-term or short-term capital gain/loss under both the standard one-year test (IRC § 1222) and the three-year test (IRC § 1061).
2. Cross-Reference with Prime Broker Records. For each of the 14 positions, we will obtain and cross-reference the acquisition and disposition dates against the official trade confirmations and account statements maintained by Ridgeline Securities LLC. Ridgeline's records are independent of the Fund's internal records and will provide corroborating evidence of the holding periods. Any discrepancies between the Fund's internal records and Ridgeline's records must be identified and resolved before the analysis is presented to the IRS.
3. Coordination with Borwick Craine & Associates LLP. We will obtain the holding period workpapers and gain/loss calculations prepared by Borwick Craine & Associates LLP (specifically, Elliot Navarro, tax engagement partner) in connection with the preparation of the 2021 Form 1065 and related Schedules K-1. These workpapers should document the methodology used to calculate holding periods and classify gains, and will serve as the foundation for our analysis.
4. Fund Administrator Records. We will request trade blotters, execution records, and settlement statements from Greystone Fund Administration LLC to provide an additional layer of documentation. Although the fund administrator's records are generally derived from the prime broker's records, they represent an independent source that can corroborate the holding period data.
5. Lot Identification Methodology. For positions that were acquired through multiple lots over time, we will confirm that the Fund properly applied a specific identification or first-in, first-out ("FIFO") methodology to identify the lots disposed of in 2021. If specific identification was used, we will obtain the contemporaneous lot identification records (e.g., internal trade tickets, investment committee memoranda, or instructions to the prime broker specifying which lots were to be sold). If FIFO was used, we will confirm that the methodology was consistently applied across all positions.
6. Presentation to the IRS. We will prepare the holding period analysis in spreadsheet format, with supporting source documents organized by position, suitable for presentation to Revenue Agent Albrecht in response to any IDR targeting this issue. A clear, well-organized presentation will facilitate efficient resolution and minimize the risk of protracted examination.
7. Positions Near the Three-Year Threshold. For any positions where the holding period is close to the three-year threshold (e.g., positions acquired within a few weeks of the three-year lookback date), we will ensure that the supporting documentation is particularly robust and unambiguous. If the trade date versus settlement date distinction could affect the holding period classification for any position, we will analyze the applicable authority on the proper date for measuring the holding period and prepare a memorandum addressing this point.
Robert Jansen will lead the preparation of the trade-level holding period analysis upon receipt of the trade confirmations from Ridgeline Securities LLC.
VI. Issue 3: Organizational and Syndication Cost Deductions — IRC §§ 709 and 195
A. Factual Background
On its 2021 Form 1065, ICM deducted a total of $1.42 million under IRC § 709(b) as amortized organizational expenses. These expenses relate to costs incurred in connection with the Fund's formation in 2016 and have been amortized ratably over a 180-month period beginning with the month in which the Fund commenced business (June 2016). The 2021 deduction represents the sixth year of amortization under the § 709(b) election.
The IRS is expected to challenge $680,000 of the $1.42 million total deduction, arguing that this portion of the costs was improperly classified as deductible organizational expenses when it should have been classified as non-deductible, non-amortizable syndication costs. If the IRS prevails on this reclassification, the $680,000 would be permanently capitalized with no recovery through amortization or any other deduction.
The distinction between organizational expenses and syndication costs is well-established under the Code and regulations but frequently gives rise to disputes, particularly in the context of investment fund formations where a single law firm or accounting firm may perform both types of work during a single engagement. The classification of each expense depends on the nature of the underlying services, not on the identity of the service provider or the form of the invoice.
Organizational expenses, eligible for amortization under IRC § 709(b), are expenses that are (i) incident to the creation of the partnership, (ii) chargeable to capital account, and (iii) of a character that, if expended incident to the creation of a partnership having an ascertainable life, would be amortizable over such life. Typical examples include legal fees for drafting the partnership agreement, accounting fees for establishing the partnership's initial accounting system, and filing fees paid to the state of formation.
Syndication costs, which are permanently non-deductible under IRC § 709(a), are expenses connected with the issuance and marketing of partnership interests. Typical examples include printing costs for offering materials, brokerage fees and placement agent commissions, registration fees, legal fees for preparing securities law opinions and private placement memoranda, and accounting fees for preparing financial projections or other materials for prospective investors.
The $680,000 at issue appears to consist primarily of legal fees incurred during the Fund's 2016 formation. Based on our preliminary review, these fees were paid to the law firm or firms that handled the Fund's formation, and the invoices may cover a range of services including both partnership agreement drafting (organizational) and private placement memorandum preparation (syndication). The critical question is whether the $680,000 in challenged expenses can be shown to relate to organizational activities (partnership formation, LPA drafting, structural advice) rather than syndication activities (investor marketing, offering document preparation, securities law compliance).
B. Applicable Legal Authority
IRC § 709(a) provides the general rule that no deduction shall be allowed for amounts paid or incurred to organize a partnership or to promote the sale of (or to sell) an interest in such partnership (i.e., syndication costs). This blanket disallowance applies to both current deductions and amortization — syndication costs may not be deducted or amortized under any provision of the Code.
IRC § 709(b) creates a limited exception to the § 709(a) disallowance by permitting a partnership to elect to amortize organizational expenses over a period of not less than 180 months, beginning with the month in which the partnership begins business. In addition, a partnership may elect to deduct up to $5,000 of organizational expenses in its first taxable year, with the $5,000 amount reduced dollar-for-dollar to the extent that total organizational expenses exceed $50,000.
IRC § 195 addresses start-up expenditures, which constitute a third category of pre-opening costs that is conceptually distinct from both organizational expenses and syndication costs. Start-up expenditures are costs that would be deductible as ordinary and necessary business expenses under IRC § 162 if incurred in connection with an existing active trade or business, but that are incurred before the partnership's business begins. While § 195 is less directly relevant to this issue, the IRS may attempt to argue that certain expenses classified by ICM as organizational expenses are more properly characterized as start-up expenditures (which are subject to a similar but separately administered amortization regime) or as syndication costs (which are permanently non-deductible).
Treasury Regulation § 1.709-2(a) provides a detailed definition of organizational expenses, including the following examples: legal fees for negotiation and preparation of a partnership agreement, accounting fees for services incident to the organization of the partnership, and filing fees paid to governmental agencies. The regulation emphasizes that the expense must be "incident to the creation" of the partnership and "chargeable to capital account."
Treasury Regulation § 1.709-2(b) defines syndication costs with corresponding specificity, providing the following examples: brokerage fees, registration fees, legal fees of the underwriter or placement agent and the issuer for securities advice and for preparation of the prospectus or private placement memorandum, printing costs of the prospectus, selling and promotional material, and other selling and promotional expenses. The regulation also states that syndication costs include accounting fees for preparation of representations to be included in the offering materials.
The key analytical distinction between organizational expenses and syndication costs turns on the purpose of the expenditure: whether the expense relates to creating the partnership entity and establishing its governance structure (organizational) or to marketing and selling partnership interests to investors (syndication). In many fund formation engagements, these two categories of work are performed concurrently by the same professionals, making the classification exercise inherently factual and dependent on the granularity of the underlying time records and invoices.
C. Risk Assessment
The amount at issue for this issue is $680,000, representing the portion of the amortized organizational expense deduction that the IRS is expected to reclassify as non-deductible syndication costs.
The potential tax impact of an adverse determination is approximately $251,600, calculated as $680,000 multiplied by the top marginal ordinary income rate of 37%. This impact is borne proportionally across all partners through the partnership in proportion to their respective allocable shares. Of the three issues under examination, this issue involves the smallest dollar amount and the most limited tax exposure.
We assess the risk level for this issue as low to moderate. The characterization question is inherently factual, and the outcome depends almost entirely on the nature of the underlying services reflected in the formation-era invoices. If the invoices from the law firm(s) that handled ICM's 2016 formation are sufficiently detailed — with line-item descriptions and time entries that clearly distinguish between partnership agreement drafting (organizational) and private placement memorandum/offering document preparation (syndication) — the IRS challenge can be rebutted by demonstrating that the $680,000 at issue relates exclusively to organizational activities.
However, a significant complication exists: legal fees for fund formation work frequently involve blended tasks. It is common for a single attorney to work on both the limited partnership agreement and the private placement memorandum during the same time period, and for invoices to reflect aggregate time entries covering both types of work. If the invoices from ICM's formation counsel lack sufficient granularity to parse organizational from syndication activities on a line-by-line basis, the IRS may argue that the insufficiently documented expenses should default to syndication treatment, relying on the principle that the taxpayer bears the burden of substantiating the deductibility of claimed expenses.
An additional risk factor is that the IRS has historically taken an aggressive position on the organizational/syndication distinction, particularly in the context of investment fund formations. IRS examiners may argue that the majority of legal work performed during a fund's formation relates to the marketing and sale of partnership interests (syndication), with only a relatively small portion attributable to the creation of the partnership entity itself (organizational). This argument has some intuitive appeal in the hedge fund context, where the economic purpose of the formation is to raise capital from investors, and the partnership agreement is in many respects a marketing document as much as an organizational one.
Notwithstanding these risks, the dollar amount at issue is relatively modest, and we believe the position is defensible with adequate documentation.
D. Preliminary Defense Strategy
Our preliminary defense strategy for Issue 3 is organized around the following elements:
1. Invoice Review and Analysis. The first and most important step is to obtain the original legal invoices from the law firm or firms that handled ICM's 2016 formation. We will identify which firm or firms performed the formation work and whether the invoices include detailed time entries that distinguish between partnership agreement drafting and structuring (organizational) and private placement memorandum preparation and securities law compliance (syndication).
2. Formation-Era Documentation. We will obtain the Ironside Capital GP LLC board resolutions from 2016 relating to the Fund's formation and initial capital raise. These resolutions may provide useful context regarding the nature and scope of the legal work commissioned by the GP in connection with the formation.
3. Fenwick Craine Workpapers. We will review the workpapers prepared by Borwick Craine & Associates LLP (Sandra Whitmore, audit engagement partner; Elliot Navarro, tax engagement partner) in connection with the original classification of organizational and syndication costs on the 2016 Form 1065 and the computation of amortization schedules through the 2021 return. These workpapers should document the methodology and rationale used to allocate formation-era expenses between the two categories.
4. Allocation Schedule. If the invoices are sufficiently detailed, we will prepare a comprehensive allocation schedule that maps each invoice line item to either the organizational or syndication category, with supporting rationale for each classification. This schedule should be structured so that it can be presented to the IRS in response to an IDR or during an examination conference.
5. Supplemental Evidence. If the invoices lack sufficient granularity to support a line-by-line allocation, we will consider obtaining affidavits or declarations from the attorneys who performed the formation work. These declarations would describe the nature of the services rendered, the approximate time spent on organizational versus syndication activities, and the basis for the classification of each category of expense. While such after-the-fact evidence is inherently less persuasive than contemporaneous documentation, it may be necessary to fill gaps in the invoice record.
6. Substantive Argument. On the merits, we will argue that the $680,000 at issue relates to partnership agreement negotiation, amendment, and structuring — work that is directly "incident to the creation of the partnership" within the meaning of Treas. Reg. § 1.709-2(a) and therefore constitutes an organizational expense eligible for amortization under IRC § 709(b). We will distinguish this work from the preparation of the private placement memorandum, subscription agreements, and investor marketing materials, which ICM has properly classified as syndication costs. To the extent that the GP retained separate counsel or separate engagement teams for organizational and syndication work, this distinction will be easier to demonstrate.
VII. Aggregate Exposure Summary
A. Partnership-Level Adjustment Amounts
The following table summarizes the potential partnership-level adjustments across all three issues:
B. Estimated Tax Impact
The following table summarizes the estimated tax impact of an adverse determination on each issue, calculated across all affected partners:
These estimates are preliminary and are based on the assumption that all affected partners are subject to the maximum marginal tax rates. Actual tax impact will vary based on individual partner circumstances, including the tax-exempt status of certain institutional investors (e.g., Northgate Public Employees' Retirement System), the availability of offsetting losses or credits, and the application of state and local income taxes.
Under the BBA centralized audit regime, the partnership-level "imputed underpayment" computation may differ from the aggregate partner-level tax impact, as the imputed underpayment is calculated using the highest applicable rate without regard to individual partner circumstances. The availability of modification procedures under IRC § 6225(c) — including the "amended return" modification, the "tax-exempt partner" modification, and the "rate modification" — could significantly reduce the imputed underpayment if the examination results in a notice of proposed partnership adjustment ("NOPPA"). We will analyze the potential benefits of these modification procedures in greater detail as the examination progresses.
C. Risk Ranking
Based on our preliminary analysis, we rank the three issues as follows in order of decreasing risk:
Issue 1 — Management Fee Waiver (IRC § 707(a)(2)(A)): Moderate to significant risk. This issue presents the greatest legal complexity and the highest audit priority for the IRS, given the LB&I Division's targeted campaign against fee waiver and conversion structures. However, the factual profile of ICM's arrangement — involving genuine downside risk, prospective election, and no preferential return — distinguishes it from the abusive structures targeted by IRS Notice 2015-54 and provides a strong foundation for defense. The estimated tax exposure is approximately $4.95 million.
Issue 2 — Carried Interest Holding Period (I

INTERNAL MEMORANDUM

MATTER NO.: 1023-00003

Record

Parties

Dates

Amounts